| Drug class | Drug | Major enzymes | FDA drug labels including pharmacogenetics information
| CYPs | UGBTs | SULTs |
| Analgesic/ antipyretics | Paracetamol | 3A4, 2E1, 2A6, 1A2, 2D6, 2C19, 2C9, 2E1, 2A6 | 1A6, 1A9 | 1A1 | In combination with tramadol CYP2D6 |
|
NSAIDs | Ibuprofen | 2C9, 2C8, 3A4, 2C19, 2C9, 2C8, 3A4, 2C19 | 2B7, 1A9, 1A3, 2B4 | | | Diclofenac | 2C9, 2C8, 3A4, 2C19 | 2B7, 2B4, 1A3, 1A9 | | | Naproxen | 2C9, 1A2 | | | | Ketoprofen | | 2B7 | | | Meloxicam | 2C9, 3A4 | | | |
| Coxibs | Celecoxib | 2C9, 3A4 | | | CYP2C9 | Etoricoxib | 3A4, 2C9, 2D6, 1A2, 2C19 | | | |
| TCAs | Amitriptyline | 2C19, 2C8, 2C9, 1A2, 2D6, 3B6, 3A4 | 1A3, 1A4 | | CYP2D6 | Nortiyptyline | 2D6, 3A4 | | | CYP2D6 | Imipramine | 2D6, 2C19, 1A2 | | | CYP2D6 | Desipramine | 2D6 | | | CYP2D6 |
| SNRIs | Duloxetine | 2D6, 1A2 | | | | Venlafaxine | 2D6, 2C19, 2C9 | | | CYP2D6 |
| | Fluoxetine | 2C9, 3A4, 2D6, 2C19, 1A2 | | | In combination with olanzapine, and CYP2D6 | SSRIs | Paroxetine | 2D6 | | | CYP2D6 | | Citalopram | 3A4, 2C19, 2D6 | | | CYPs 2C19, and 2D6 |
| Antiepileptics | Carbamazepine | 3A4, 2C8 | 2B7 | | | Valproate | | 2B7, 1A6, 1A9 | | |
| Opioids | Buprenorphine | 3A4, 2C8 | 1A1, 2B7, 1A3 | | | Codeine | 2D6, 3A4 | 2B7, 2B4 | | CYP2D6 | Dihydrocodeine | 2D6, 3A4 | 2B7 | | | Morphine | 3A4, 2C8 | 2B7, 1A8, 1A1, 1A3, 1A10, 1A6, 1A1 | | | Oxycodone | 2D6, 3A4 | 2B7 | | | Pethidine | 3A4, 2B6, 2C19 | | | | Tilidine | 3A | | | | Tramadol | 3A4, 2B6 | | | In combination with paracetamol CYP2D6 |
|
|